Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen
AbstractWe investigated 143 patients with various classes of liver disease and 120 healthy subjects for serological markers of hepatitis C and B viruses. We found a prevalence rate of 37.1% of anti-HCV markers in patients with liver disease [cases], and 4.2% and in the control group. HBsAg was detected in 33.6% of cases and 13.3% of the controls. Anti-HCV and HBsAg were detected in 7.7% of cases but were not detected in the controls. Anti-HCV, HBsAg, anti-HBe and anti-HDV were detected in three patients. Serum protein electrophoresis results showed elevated gammaglobulin and low albumin in patients positive for anti-HCV who had liver disease
Al Moslih, M.I. & Al Huraibi, M.A. (2001). Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen. http://www.who.int/iris/handle/10665/119087
EMHJ - Eastern Mediterranean Health Journal, 7 (4-5), 771-778, 2001
MetadataShow full item record
Showing items related by title and MeSH subject.
Report on the regional workshop on standardization of histological criteria for diagnosis of liver diseases including liver cancer, Karachi, 7-12 February 1981 World Health Organization, Regional Office for the Eastern Mediterranean (EM/CAN/66EM/LD/2EM/WKP.STD.HST.CRT.DGN.LIV.DIS.LIV.CAN./3, 1981)
Rikabi, A.; Bener, A.; Al Marri, A.; Al Thani, S. (2009)We investigated the incidence of hepatitis B [HBV] and C [HCV] virus infection among patients with liver disease in Qatar from 2000 to 2005. The grading and staging of HBV and HCV cases were obtained from pathology reports at the principal reference laboratory for Qatar. Of the 915 liver patients studied, 29.4% had HCV and 2.5% had HBV. The incidence of HBV and HCV infection was greater in non-Qataris than Qatari nationals and in males than females, especially for HCV. Most cases were uncomplicated [89.0%] and had no inflammation [76.4%]. The ...